Assignee
ENANTA PHARM INC
US·238 granted patents·45 pending applications·2,209 citations·filing 2000–2025
Top patents by PatentIndex Score
283 records- 0198US11560368B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2021·Granted Jan 24, 2023·6 cites·18 claims
- 0298US11384090B2Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted Jul 12, 2022·14 cites·15 claims
- 0398US11352363B1Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted Jun 7, 2022·13 cites·9 claims
- 0498US11339170B1Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted May 24, 2022·17 cites·18 claims
- 0598US11325916B1Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted May 10, 2022·16 cites·15 claims
- 0698US11319325B1Macrocyclic spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted May 3, 2022·14 cites·24 claims
- 0798US10865215B2Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2020·Granted Dec 15, 2020·16 cites·13 claims
- 0898US10683279B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2018·Granted Jun 16, 2020·13 cites·18 claims
- 0998US10358441B2Processes for the preparation of benzodiazepine derivativesENANTA PHARM INC·Filed 2018·Granted Jul 23, 2019·27 cites·18 claims
- 1098US10189846B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2017·Granted Jan 29, 2019·25 cites·8 claims
- 1198US10179131B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2016·Granted Jan 15, 2019·27 cites·15 claims
- 1298US7635683B2Quinoxalinyl tripeptide hepatitis C virus inhibitorsENANTA PHARM INC·Filed 2006·Granted Dec 22, 2009·75 cites·5 claims
- 1397US11858945B2Alkyne-containing antiviral agentsENANTA PHARM INC·Filed 2022·Granted Jan 2, 2024·7 cites·16 claims
- 1497US11596611B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2021·Granted Mar 7, 2023·5 cites·13 claims
- 1597US11420976B2Heterocyclic compounds as anti-viral agentsENANTA PHARM INC·Filed 2021·Granted Aug 23, 2022·7 cites·23 claims
- 1697US11390631B1Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2020·Granted Jul 19, 2022·4 cites·10 claims
- 1797US10988458B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2020·Granted Apr 27, 2021·7 cites·23 claims
- 1897US10428070B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2018·Granted Oct 1, 2019·24 cites·17 claims
- 1997US9957281B2Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2016·Granted May 1, 2018·32 cites·18 claims
- 2097US7605126B2Acylaminoheteroaryl hepatitis C virus protease inhibitorsENANTA PHARM INC·Filed 2006·Granted Oct 20, 2009·38 cites·15 claims
- 2197US7582605B2Phosphorus-containing hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2006·Granted Sep 1, 2009·59 cites·9 claims
- 2297US7273853B26-11 bicyclic ketolide derivativesENANTA PHARM INC·Filed 2005·Granted Sep 25, 2007·35 cites·29 claims
- 2397US7176208B2Quinoxalinyl macrocyclic hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2004·Granted Feb 13, 2007·111 cites·10 claims
- 2496US12011425B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2023·Granted Jun 18, 2024·1 cites·17 claims
- 2596US11919910B2Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2022·Granted Mar 5, 2024·5 cites·13 claims
- 2696US11912714B2Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2022·Granted Feb 27, 2024·6 cites·13 claims
- 2796US11505558B1Antiviral heterocyclic compoundsENANTA PHARM INC·Filed 2021·Granted Nov 22, 2022·8 cites·21 claims
- 2896US10952978B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2018·Granted Mar 23, 2021·6 cites·14 claims
- 2996US10538532B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2018·Granted Jan 21, 2020·17 cites·15 claims
- 3096US7687459B2Arylalkoxyl hepatitis C virus protease inhibitorsENANTA PHARM INC·Filed 2007·Granted Mar 30, 2010·26 cites·18 claims
- 3196US7601709B2Macrocyclic hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2004·Granted Oct 13, 2009·60 cites·75 claims
- 3296US7368452B2Quinoxalinyl macrocyclic hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2006·Granted May 6, 2008·35 cites·12 claims
- 3396US7273851B2Tri-peptide hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2004·Granted Sep 25, 2007·65 cites·18 claims
- 3496US7189704B26-11 bicyclic ketolide derivativesENANTA PHARM INC·Filed 2005·Granted Mar 13, 2007·15 cites·22 claims
- 3595US11912695B2Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2022·Granted Feb 27, 2024·5 cites·20 claims
- 3695US11572367B2Antiviral heterocyclic compoundsENANTA PHARM INC·Filed 2020·Granted Feb 7, 2023·9 cites·21 claims
- 3795US11358953B2Functionalized peptides as antiviral agentsENANTA PHARM INC·Filed 2021·Granted Jun 14, 2022·15 cites·10 claims
- 3895US11254664B2Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2020·Granted Feb 22, 2022·7 cites·19 claims
- 3995US10968249B2Bile acid derivatives as FXR/TGR5 agonists and methods of use thereofENANTA PHARM INC·Filed 2020·Granted Apr 6, 2021·3 cites·12 claims
- 4095US10729688B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2019·Granted Aug 4, 2020·11 cites·19 claims
- 4195US10683289B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2019·Granted Jun 16, 2020·10 cites·19 claims
- 4295US10676500B2Process for preparation of sulfonyl carbamate bile acid derivativesENANTA PHARM INC·Filed 2018·Granted Jun 9, 2020·7 cites·8 claims
- 4395US10584145B2Process for preparation of sulfonylurea bile acid derivativesENANTA PHARM INC·Filed 2017·Granted Mar 10, 2020·8 cites·14 claims
- 4495US10450301B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2018·Granted Oct 22, 2019·11 cites·20 claims
- 4595US10398706B2Heteroaryldiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2018·Granted Sep 3, 2019·26 cites·11 claims
- 4695US10246439B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2018·Granted Apr 2, 2019·12 cites·20 claims
- 4795US10179792B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2017·Granted Jan 15, 2019·17 cites·13 claims
- 4894US12018017B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2022·Granted Jun 25, 2024·1 cites·14 claims
- 4994US12006326B2Antiviral heterocyclic compoundsENANTA PHARM INC·Filed 2022·Granted Jun 11, 2024·3 cites·18 claims
- 5094US11945830B2Antiviral heterocyclic compoundsENANTA PHARM INC·Filed 2022·Granted Apr 2, 2024·3 cites·18 claims
Showing the top 50 of 283 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ENANTA PHARM INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →